| Gary W Reimers, LPN | |
|
990 Marlandwood Rd, Temple, TX 76502-3365 | |
| (254) 771-0852 | |
| Not Available |
| Full Name | Gary W Reimers |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 990 Marlandwood Rd, Temple, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730741703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 146928 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gary W Reimers, LPN 990 Marlandwood Rd, Temple, TX 76502-3365 Ph: (254) 771-0852 | Gary W Reimers, LPN 990 Marlandwood Rd, Temple, TX 76502-3365 Ph: (254) 771-0852 |
News Archive
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
Myriad Genetics, Inc. today announced that it has signed an agreement with Abbott Laboratories, a global health care company, to conduct BRCA1 and BRCA2 mutation testing on patients to be enrolled in a Phase III multi-center, multi-national clinical study of a novel drug candidate for the treatment of metastatic breast cancer.
Women face a 20% increased risk of developing heart failure or dying within five years after their first severe heart attack compared with men.
Many scientists have explored the use of new as well as already approved drugs for this condition, and one of the very few promising leads is dexamethasone. Dexamethasone is a corticosteroid, which has been reported in some earlier studies to reduce mortality in these patients by 18% and 36% in COVID-19 patients who are on oxygen and ventilators, respectively.
› Verified 4 days ago
Cynthia Furr, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1107 S 11th St, Temple, TX 76504 Phone: 254-563-0175 | |
Heather Lynn Mclaughlin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 601 Twin Oaks Dr Apt 506, Temple, TX 76504 Phone: 772-233-6838 | |
Victoria Lynn Morton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6102 W Adams Ave, Temple, TX 76502 Phone: 254-252-5757 | |
Taeseon Hwang, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3101 W Adams Ave Apt 205, Temple, TX 76504 Phone: 254-316-8964 | |
Rebecca Keala-ka'a Hanrahan, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 990 Marlandwood Rd, Temple, TX 76502 Phone: 317-979-5480 | |
Michael John Enderby, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1901 Veterans Memorial Dr, Temple, TX 76504 Phone: 920-327-9721 |